Hoth Therapeutics 2021 Clinical-Stage Biopharmaceutical Investor Presentation

Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics to address unmet patient needs. The company identifies and develops early-stage drug candidates for rare and chronic diseases, emphasizing treatments with improved safety profiles. Hoth partners with leading companies to advance its pipeline and bring therapies to market.